newest glp-1 New Guidelines for Type 2 Diabetes in 2025 For best results GLP-1 Agonists: A Comprehensive Overview

GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice

[DOI] [PMC free article] [PubMed] [Google Scholar] 9.ELIXA trial show CV safety of lixisenatide

Clinically, long acting GLP-1 mimetics are now used to treat Type 2 diabetes

The FormBlends dosing calculator helps structure these multi-compound protocols, and the free assessment provides personalized recommendations based on individual health profiles

It cooks in under five minutes

GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss